Hologic Financial Statements From 2010 to 2026

HOLX Stock  USD 74.91  0.16  0.21%   
Hologic's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Hologic's valuation are provided below:
Hologic does not presently have any fundamental trends for analysis.
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as , as well as many indicators such as . Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Hologic Company Profit Margin Analysis

Hologic's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Hologic Profit Margin

    
  0.14 %  
Most of Hologic's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hologic is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Hologic has a Profit Margin of 0.138%. This is 101.23% lower than that of the Health Care Equipment & Supplies sector and 100.76% lower than that of the Health Care industry. The profit margin for all United States stocks is 110.87% lower than that of the firm.

Hologic Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Hologic's current stock value. Our valuation model uses many indicators to compare Hologic value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hologic competition to find correlations between indicators driving Hologic's intrinsic value. More Info.
Hologic is rated below average in return on equity category among its peers. It is rated # 5 in return on asset category among its peers reporting about  0.66  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hologic is roughly  1.52 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hologic's earnings, one of the primary drivers of an investment's value.

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Hologic operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6705 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.